戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 moval at 6 weeks after transplantation (with cystoscopy).
2                  Figure 5: Image obtained at cystoscopy.
3 detected on a preliminary ultrasonography or cystoscopy.
4          Only 2 cases required extraction by cystoscopy.
5 "mixed flora" in an elderly male following a cystoscopy.
6 ns in comparison to conventional white light cystoscopy.
7 tive results, and are unlikely to substitute cystoscopy.
8 nce that any marker can replace surveillance cystoscopy.
9 , 72% (142 of 197), and 99% (634 of 641) for cystoscopy.
10 including implementing robotics and flexible cystoscopy.
11 ntinues to rely on direct visualization with cystoscopy.
12 short-term recurrence rates than white light cystoscopy.
13 lysis of NMP22 protein and cytology prior to cystoscopy.
14 ice (9 or 15 Fr) has been developed to spare cystoscopy.
15  have been made in the field of fluorescence cystoscopy.
16 hypericin) and their application to flexible cystoscopy.
17 ved sensitive and specific enough to replace cystoscopy.
18  this technique can be used for office-based cystoscopy.
19                     The diagnosis is made by cystoscopy.
20 ssibly play a complementary role to standard cystoscopy.
21 ew developments in the field of fluorescence cystoscopy.
22 died to improve the accuracy of fluorescence cystoscopy.
23 plasms underwent CT virtual and conventional cystoscopy.
24 aturia and abnormal findings at conventional cystoscopy.
25 agement and reduce the need for surveillance cystoscopies.
26                              At conventional cystoscopy, 29 masses appeared to arise from the bladder
27                                   At virtual cystoscopy, 30 masses arose from the bladder (one prosta
28                                       Use of cystoscopy (8.1%) and sigmoidoscopy or proctoscopy (8.6%
29 ot significantly increase the sensitivity of cystoscopy (94.2%; 95% CI, 87.7%-97.8%; P = .08).
30         Based on the ultrasound, CT, MRI and cystoscopy, a local recurrence of cancer was presumed in
31                                              Cystoscopy alone identified 91.3% of the cancers (94/103
32  to the invasiveness and expense of frequent cystoscopies and the lack of sensitivity of urinary cyto
33                                              Cystoscopy and biopsy showed a 4-cm mass at the right ur
34  evidence of disease at their post-treatment cystoscopy and biopsy.
35 Studies were stratified by the percentage of cystoscopy and CT urography use and by high-risk cohorts
36 ative limitations of the current standard of cystoscopy and cytology, there has been burgeoning activ
37  3 of the malignancies missed during initial cystoscopy and did not significantly increase the sensit
38 nicians should consider urology referral for cystoscopy and imaging in adults with microscopically co
39 ts who had bladder abnormalities noted using cystoscopy and in 1 patient with an increased prostate-s
40         The follow-up CT cystogram, flexible cystoscopy and pelvic MRI confirmed the diagnosis of EC
41 mour cells, the modality used for diagnostic cystoscopy and possible gender-associated differences.
42            The mainstay of diagnosis remains cystoscopy and transurethral resection, with enhanced op
43 croscopic hematuria, which is evaluated with cystoscopy and upper tract imaging depending on the degr
44  its availability in both flexible and rigid cystoscopy and ureteroscopy and its potential for detect
45  cancer or progressive disease), assessed by cystoscopy and urine cytology approximately 3 months aft
46          Stratification of studies that used cystoscopy and/or CT urography for 95% or more of the co
47 ctively compared with results of urinalysis, cystoscopy and/or ureteroscopy, and/or surgery.
48        Thus, BLFC has a role in surveillance cystoscopy, and determining which patients will benefit
49 , as many 'routine cases' when examined with cystoscopy are found to be associated with complications
50 theter was removed in a joint manner without cystoscopy at 2 weeks.
51 ients were assigned to 2nd TURB or follow-up cystoscopy at 3 months (FU) by clinicians' discretion.
52 ients with nonglomerular hematuria (82%) had cystoscopy at the NIH.
53                                   Blue light cystoscopy (BLC) with hexaminolevulinate (HAL) during tr
54 ive multicentre study of blue light flexible cystoscopy (BLFC) in surveillance of intermediate-risk a
55 opy were comparable to those at conventional cystoscopy but were obtained without the associated risk
56 were significant variations in the prices of cystoscopy (chi23 = 85.9; P = .001), prostate biopsy (ch
57                                              Cystoscopy continues to be routinely used, as many 'rout
58 cancer or progressive disease as assessed by cystoscopy, cytology, and central pathology and radiolog
59 logical complications (UCs), but it requires cystoscopy extraction.
60 rs may be a useful alternative or adjunct to cystoscopy for diagnosis of bladder cancer.
61   Forty-two of the 60 patients (70%) who had cystoscopy had macroscopic changes consistent with cyclo
62  agents to the armamentarium of fluorescence cystoscopy has great potential with promising results in
63  usually used in the clinic as an adjunct to cystoscopy; however, it suffers from low sensitivity.
64 could be generated based on archived patient cystoscopy images.
65                             While blue light cystoscopy improves diagnostic sensitivity, it remains a
66                       Stones were removed by cystoscopy in 11 (55%) patients.
67  number of articles have examined the use of cystoscopy in all cases of complicated pelvic surgery an
68                                   Diagnostic cystoscopy in combination with transurethral resection o
69 raphy in patients with hematuria may obviate cystoscopy in selected patients.
70 ase II and III trials outperform white light cystoscopy in terms of cancer detection and recurrence-f
71 recent literature on the use of fluorescence cystoscopy in the diagnosis and management of bladder ca
72                                     Enhanced cystoscopy includes technology used to improve the detec
73 cers that were not visualized during initial cystoscopy, including 7 that were high-grade.
74 d for NMIBC, such as undetected tumours upon cystoscopy, incomplete resection during TURBT, tumour re
75                        Rates of surveillance cystoscopy increased over the study period, with patient
76 gists blinded to the results of conventional cystoscopy independently reviewed the transverse and vir
77                                   CT virtual cystoscopy is a promising technique for use in bladder t
78                                              Cystoscopy is currently the "gold standard," but it is i
79                   CT urography combined with cystoscopy is emerging as the diagnostic imaging pathway
80                                              Cystoscopy is standard but can fail to detect some bladd
81 orporating this technology into surveillance cystoscopy must be developed.
82                     However, at that time, a cystoscopy of his primary tumor and a transurethral rese
83 ses of extravasation were preceded by recent cystoscopy or placement of a Foley catheter; one case wa
84 ither early stent removal at 5 days (without cystoscopy) or late removal at 6 weeks after transplanta
85 mor growth from imaging studies, findings at cystoscopy, or histologic interpretation of biopsies.
86 the routine use of barium enema examination, cystoscopy, or proctoscopy.
87 iod, with patients receiving a median of 3.0 cystoscopies per year (IQR, 2.0-4.0 per year).
88 de replacement or reduction in the number of cystoscopies performed in the surveillance of bladder ca
89  a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses an
90      Morbidity is substantial, with frequent cystoscopy, recurrence, resections, and possible cystect
91                                              Cystoscopy remains the gold standard for diagnosis of bl
92                                              Cystoscopy remains the mainstay in the detection and sur
93                                              Cystoscopy remains the mainstay in the detection and sur
94                                              Cystoscopy remains the mainstay in the detection and sur
95                                              Cystoscopy reports were classified as positive if a lesi
96 er tumors can be detected using fluorescence cystoscopy resulting in improved cancer detection and lo
97 eated for bladder cancer and having negative cystoscopy results.
98                                 Fluorescence cystoscopy should be considered as an adjunctive tool fo
99                                              Cystoscopy showed a viable transplanted bladder with a w
100 eliminary results with flexible fluorescence cystoscopy suggest that this technique can be used for o
101           Translational advances in enhanced cystoscopy technologies and artificial intelligence offe
102                                              Cystoscopy, the current gold standard diagnosis approach
103 o improve the utility of urinary markers and cystoscopy through fluorescence endoscopy.
104  used in conjunction with urine cytology and cystoscopy to improve clinical diagnosis of bladder canc
105  endpoint was CR at 12 months as assessed by cystoscopy, urine cytology, cross-sectional imaging and
106 ivo in swine and with retrospective clinical cystoscopy video.
107 renceable bladder map rendered from standard cystoscopy videos without the need for specialized equip
108                                      Virtual cystoscopy was performed in 13 patients with hematuria a
109                                              Cystoscopy was repeated 6 weeks after therapy.
110    The diagnostic yields of CT urography and cystoscopy were calculated for each cancer type.
111                           Results at virtual cystoscopy were comparable to those at conventional cyst
112 of 40 bladder lesions proved at conventional cystoscopy were detected with a combination of transvers
113 ce characteristics for both CT urography and cystoscopy were determined by using pathologic findings
114 ndard for the diagnosis of bladder cancer is cystoscopy, which is invasive and painful for patients.
115           The patient subsequently underwent cystoscopy, which revealed an intravesicular fluid-fille
116           The patient subsequently underwent cystoscopy, which revealed an intravesicular fluid-fille
117                                 Fluorescence cystoscopy with 5-aminolevulinic acid and hexaminolevuli
118                    Efficacy was evaluated by cystoscopy with biopsy, cytology, and computed tomograph
119 nosis of bladder cancer recurrence, based on cystoscopy with biopsy, was accepted as the reference st
120 samples from postmenopausal women undergoing cystoscopy with fulguration of trigonitis in the advance
121                           The combination of cystoscopy with the NMP22 assay detected 99.0% of the ma
122 cent advances have been made in fluorescence cystoscopy with the use of newer fluorescence agents (he
123 ladder cancer rely heavily on routine office cystoscopy, with few advances in diagnostic and treatmen
124 tory of urothelial cancer, who had undergone cystoscopy within 6 months of the CT urogram, were inclu

 
Page Top